News
About Us
About Us
Business Strategy
Business Strategy
- Business Model
- Life Cycle Management Strategy
Technology
Technology
- SLC Transporters
- LAT1 Inhibitors
Pipeline
Pipeline
Clinical Trials
Clinical Trials
- Biliary Tract Cancer Phase III
- JPH034　Phase 1
IR
IR
- IR Library
  
  Financial Results
  
  Presentation Materials
  
  IR Materials
- Stock Information
  
  Stock Overview
  
  General Meeting of Shareholders
- Disclaimer

Top＞News Lists＞JPH203 Phase I result will be presented at ASCO Annual Meeting

2018.05.23

JPH203 Phase I result will be presented at ASCO Annual Meeting

About Us
Business Strategy
- Business Model
- Life Cycle Management Strategy
Technology
- SLC Transporters
- LAT1 Inhibitors

Pipeline
Clinical Trials
- Biliary Tract Cancer Phase III
- JPH034　Phase 1
IR
- Top Message
- Disclosure Policy
- Financial Highlights
- IR Calendar
- IR Library
- Stock Information
  - Stock Overview
  - General Meeting of Shareholders
- Disclaimer

Contact

Privacy Policy
Management System for Public Research Funds

Copyright © J-Pharma Co.,Ltd. All Rights Reserved.